ARCHIVES

Nexavar Improves PFS In HER-2 Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 5 | May 27, 2011

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups Fight Back: Members Seek Move To Multidisciplinary Approach, More Funds

May 30, 1975

White House Yet To Name NCAB, Cancer Panel Members

February 11, 2011

FDA Approves Abraxane And Alimta for NSCLC

October 26, 2012

Karmanos Cancer Institute, CDC, Blue Cross To Begin Environmental Cancer Program

June 4, 2010

NEJM Does About-Face, Issues Correction On CT Lung Cancer Screening Study.

April 4, 2008

NIH Considering Intramural NRSA, NCI Advisors Not Enthusiastic

February 17, 1984